FDA warns of fetal risk of two transplant drugs
WASHINGTON (Reuters) - U.S. health officials issued an alert on Friday about the risk of first-trimester miscarriages and birth defects from Novartis AG and Roche Holding AG transplant drugs.
More: continued here
Leave a Reply
You must be logged in to post a comment.